FindTrial
Sign In

Faecal microbiota transplant

BIOLOGICAL3 trials

Sponsors

Hospital Universitario Dr. Jose E. Gonzalez, Imperial College London, University of Birmingham

Conditions

Chronic Kidney Disease Due to HypertensionChronic Kidney Disease Due to Type 2 Diabetes MellitusFecal Microbiota TransplantationInflammatory Bowel DiseasesNon-Alcoholic Fatty Liver DiseasePrimary Sclerosing Cholangitis

Phase 2

FAecal Microbiota Transplantation in primaRy sclerosinG chOlangitis
RecruitingNCT06286709
University of BirminghamInflammatory Bowel Diseases, Primary Sclerosing Cholangitis
Start: 2024-03-27End: 2027-02-28Target: 58Updated: 2026-04-29

Unknown Phase

Fecal Microbiota Transplantation as a Therapeutic Strategy in the Progression of Chronic Kidney Disease
CompletedNCT04361097
Hospital Universitario Dr. Jose E. GonzalezChronic Kidney Disease Due to Hypertension, Chronic Kidney Disease Due to Type 2 Diabetes Mellitus
Start: 2018-08-07End: 2020-04-21Updated: 2020-04-28
Impact of FMT on the Phenome in Patients With NAFLD and Fibrosis
CompletedNCT06024681
Imperial College LondonFecal Microbiota Transplantation, Non-Alcoholic Fatty Liver Disease
Start: 2021-07-20End: 2023-10-31Updated: 2024-03-06

Related Papers

Unraveling the Gut-Liver-Brain Axis: Microbiome, Inflammation, and Emerging Therapeutic Approaches.
2025-06-186 citations
FAecal micRobiota transplantation in primary sclerosinG chOlangitis (FARGO): study protocol for a randomised, multicentre, phase IIa, placebo-controlled trial
BMJ Open2025-01-018 citations
Changes in the Progression of Chronic Kidney Disease in Patients Undergoing Fecal Microbiota Transplantation
Nutrients2024-04-1031 citations